Canada· CA-DIN-02414678
PREMARIN
A conjugated estrogens product containing conjugated estrogens, registered in Canada by PFIZER CANADA ULC. The same ATC class is registered in 3 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Conjugated estrogens is registered in 3 of 19 countries.
Countries holding a registration under ATC G03CA57 (conjugated estrogens), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Conjugated estrogens · ATC G03CA57
3 / 19 countries
- Canada
- Finlandprice
- Ireland
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CONJUGATED ESTROGENS
- Manufacturer
- PFIZER CANADA ULC
- Country
- Canada (CA)
- ATC code
- G03CA57
- ATC class
- Conjugated estrogens
- Defined daily dose
- 0.625 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
146 interactions on record for conjugated estrogens.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Conjugated estrogens · interactions on record
146 records
- 7 severe
- 136 moderate
- 3 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- HeminB06AB01severe
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Conjugated estrogens in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesConjugated EstrogensPrasco Laboratories
- United KingdomConjugated oestrogens 1.25mg tabletsWaymade Healthcare Plc
- IrelandPremarin 0.625 mg Prolonged-release tabletsPfizer Healthcare Ireland Unlimited Company
- SpainEQUIN 0,6 mg COMPRIMIDOSLaboratorio Aldo Union S.L.
- FinlandPremarinWyeth Medica Ireland
- BelgiumDuavive 0.45 mg - 20 mgPfizer Europe MA
- Japan結合型エストロゲンファイザー
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Spain · Equín
- United Kingdom (Northern Ireland) · Conjugated Oestrogens Pfizer, Premarin
- Ireland · Premarin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/615e2295-4c42-4e75-a0ac-a6567512b061 GET /v1/drugs/615e2295-4c42-4e75-a0ac-a6567512b061?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02414678",
"form": "TABLET (EXTENDED-RELEASE)",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "G03CA57",
"schedule": [
"Prescription"
],
"drug_code": "89930",
"strengths": [
"0.3 MG"
],
"ahfs_class": null,
"substances": [
"CONJUGATED ESTROGENS"
],
"product_categorization": null
}See everything about conjugated estrogens.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.